Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism. 1990

J F Tohme, and J P Bilezikian, and T L Clemens, and S J Silverberg, and E Shane, and R Lindsay
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032.

Exquisite sensitivity of normal parathyroid glands to small changes in ambient calcium concentrations and impaired sensitivity in primary hyperparathyroidism have been shown in vitro. Using an assay for PTH that detects rapid changes in PTH secretion (N-terminal-specific RIA; normal range, less than 3-33 pg/mL), we determined PTH suppressibility in response to a standardized dose of oral calcium in normal subjects and patients with primary hyperparathyroidism. Nine normal subjects were given oral calcium (25 mg/kg), and blood was analyzed half-hourly for 3 h for calcium and N-terminal PTH (N-PTH). Serum calcium rose by 0.34 +/- 0.06 mg/dL (0.085 +/- 0.015 mmol/L), and N-PTH levels declined rapidly from 15.3 +/- 1.4 to 4.2 +/- 1.1 pg/mL (-73 +/- 6%; P less than 0.01). In six subjects N-PTH concentrations became undetectable. Nine patients with primary hyperparathyroidism were tested in the same manner. Serum calcium rose by 0.53 +/- 0.1 mg/dL (0.13 +/- 0.025 mmol/L), and N-PTH levels declined less, from 66 +/- 14 to 52 +/- 12 pg/mL (-21 +/- 4%; P less than 0.05). In none of the patients was the PTH reduced to less than 20 pg/mL. These results illustrate in vivo that the PTH response to oral calcium in primary hyperparathyroidism is markedly different from that in normal subjects.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010280 Parathyroid Glands Two pairs of small oval-shaped glands located in the front and the base of the NECK and adjacent to the two lobes of THYROID GLAND. They secrete PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body. Gland, Parathyroid,Glands, Parathyroid,Parathyroid Gland
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

J F Tohme, and J P Bilezikian, and T L Clemens, and S J Silverberg, and E Shane, and R Lindsay
August 1977, The Journal of clinical endocrinology and metabolism,
J F Tohme, and J P Bilezikian, and T L Clemens, and S J Silverberg, and E Shane, and R Lindsay
January 1993, Hormone research,
J F Tohme, and J P Bilezikian, and T L Clemens, and S J Silverberg, and E Shane, and R Lindsay
January 1985, Acta medica Scandinavica,
J F Tohme, and J P Bilezikian, and T L Clemens, and S J Silverberg, and E Shane, and R Lindsay
October 1971, The Quarterly journal of medicine,
J F Tohme, and J P Bilezikian, and T L Clemens, and S J Silverberg, and E Shane, and R Lindsay
April 1972, Clinical endocrinology,
J F Tohme, and J P Bilezikian, and T L Clemens, and S J Silverberg, and E Shane, and R Lindsay
June 1993, The Journal of clinical endocrinology and metabolism,
J F Tohme, and J P Bilezikian, and T L Clemens, and S J Silverberg, and E Shane, and R Lindsay
January 1982, Acta medica Scandinavica,
J F Tohme, and J P Bilezikian, and T L Clemens, and S J Silverberg, and E Shane, and R Lindsay
January 1983, The Netherlands journal of medicine,
J F Tohme, and J P Bilezikian, and T L Clemens, and S J Silverberg, and E Shane, and R Lindsay
November 1997, The New England journal of medicine,
J F Tohme, and J P Bilezikian, and T L Clemens, and S J Silverberg, and E Shane, and R Lindsay
January 2017, World journal of surgery,
Copied contents to your clipboard!